Skip to content

Study on Disease of liver due to non-alcoholic causes.

Prevalence And Determinants Of Metabolic Associated Fatty Liver Disease (MAFLD) Among People Residing In Urban And Rural Areas Of Belagavi-Community Based Comparitive Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/10/095986
Enrollment
402
Registered
2025-10-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil Intervention5: Nil: Nil

Sponsors

Dr. AMRUTHA K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age more than 18 years and less than 65 years, residing in the same area for more than 1 year.

Exclusion criteria

Exclusion criteria: 1. Patients with history of alcohol intake more than 30 grams/ day in males and more than 20 grams/day in females. 2. Patients with history of jaundice or HBsAg positive and Hepatitis “C” positive. 3. Patients with history of following drug intake steroids, synthetic oestrogens, heparin, calcium channel blockers, amiodarone, valproic acid, arsenic, mercury, homeopathic drugs, ayurvedic drugs, antiviral agents. 4. Patients having autoimmune hepatitis. 5. History of drug abuse, opium, and nicotine. 6. Patients of Coronary artery disease.

Design outcomes

Primary

MeasureTime frame
Primary objective: To evaluate the prevalence and determinants of Metabolic Associated Fatty Liver Disease (MAFLD) among people residing in urban and rural areas Timepoint: 50 weeks

Secondary

MeasureTime frame
Secondary objective: To assess the knowledge, awareness and attitude regarding Metabolic Associated Fatty Liver Disease (MAFLD) among people residing in urban and rural areasTimepoint: 50 weeks

Countries

India

Contacts

Public ContactDr Amrutha K

Jawaharlal Nehru Medical College, Belagavi.

rajesh2kulkarni@gmail.com9886010047

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026